ARIALYS
LIVE

Serial Number

99538517

Owner

Arialys Therapeutics, Inc.

Attorney

Ava R. Shelby

Filing Date

Dec 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ARIALYS Trademark

Serial Number: 99538517

ARIALYS is a trademark filed by Arialys Therapeutics, Inc. on December 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Arialys Therapeutics, Inc. (2 trademarks)

11099 North Torrey Pines Rd., Suite #290
La Jolla, CA 92037

Entity Type: 03

Trademark Details

Filing Date

December 9, 2025

Registration Date

Not Registered

Published for Opposition

May 19, 2026

Goods & Services

Allergy relief medication; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; antibiotics; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating asthma; pharmaceutical agents for epidermis; anesthetics for surgical use; cardiovascular pharmaceutical preparations; pharmaceutical products for the treatment of infectious diseases; pharmaceutical agents affecting sensory organs; antiallergic medicines; pharmaceutical preparations for peripheral nervous system; medicines for dental purposes; pharmaceutical agents affecting digestive organs; eye drops; ear drops; nasal sprays for medical purposes; medical preparation for slimming purposes; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; tumor suppressing agents; pain relief medication; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for treating hypertension; anaesthetics; alcohol for pharmaceutical purposes; diagnostic reagents for medical use; capsules sold empty for pharmaceuticals; dietetic preparations adapted for medical purposes; adhesive plasters for medical purposes; medical dressings; teeth filling material; lacteal flour for babies; nutritional supplements; baby food; dietary supplements for animals; semen for artificial insemination

Research in the field of pharmaceuticals; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; research on the subject of pharmaceuticals; drug discovery services; pharmaceutical research services; development of pharmaceutical preparations and medicines; medical research; chemical research; chemical analysis; bacteriological research; biological research; Medical and scientific research in the nature of conducting clinical trials for others; scientific research; scientific laboratory services

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 21, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 14, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 14, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 14, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 14, 2026 CNEA
ASSIGNED TO EXAMINER
Apr 14, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 9, 2025 MAFR
NEW APPLICATION ENTERED
Dec 9, 2025 NWAP